BioCentury
ARTICLE | Company News

Gold NanoTech, Shenzhen Chipscreen deal

October 21, 2013 7:00 AM UTC

Shenzhen Chipscreen granted Gold NanoTech's GNT Biotech and Medicals Corp. subsidiary exclusive rights to develop and commercialize Chidamide in Taiwan. The small molecule histone deacetylase (HDAC) ...